The Trump administration’s expansive tariff agenda is expected to increasingly focus on pharmaceuticals in the coming months, with the goal of addressing national security risks, creating domestic jobs, and onshoring of profits.
In a new video, Marta E. Wosińska explains that the actual effects of pharmaceutical tariffs are likely to be quite different.
To learn more about pharmaceutical tariffs, prescription drug shortages, and supply chain reliability, explore Marta’s related research here.
US Treasury commentary and analysis
Stabilizing the U.S. Treasury market. Shocks in Treasuries can have far-reaching ripple effects on financial markets. On a recent episode of the Brookings Podcast on Economic Activity (BPEA), David Wessel interviews Anil K Kashyap about the role of the Federal Reserve in stabilizing the Treasury market in times of distress.
Longer-term Treasury yields. As the U.S. economy weakens under the weight of recent tariffs, an odd trend has emerged: rising long-term Treasury yields. In a new analysis, Robin Brooks examines whether these increases reflect a growing fiscal risk premium in longer-term yields.
About Brookings
The Brookings Institution is a nonprofit organization based in Washington, D.C. Our mission is to conduct in-depth, nonpartisan research to improve policy and governance at local, national, and global levels. If you were forwarded this email, sign up for the Brookings Brief to stay updated on our latest work.
The Brookings Institution,1775 Massachusetts Ave NW, Washington, DC 20036
The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars.
